Drug Approval | May 06, 2022
Lupin receives USFDA approval for Pregabalin and Iloperidone
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
This product will be manufactured at Lupin’s Nagpur facility in India
The product will be manufactured at Lupin’s facility in Goa, India
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
The product will be manufactured at Lupin’s facility in Goa, India
Nebivolol is used alone or together with other medicines to treat high blood pressure
The product will be manufactured at Lupin’s facility in Goa, India
Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment
Subscribe To Our Newsletter & Stay Updated
